Effect of the Timing of Cataract Surgery on Complications in Patients With Bilateral Congenital Cataracts

Sponsor
Sun Yat-sen University (Other)
Overall Status
Completed
CT.gov ID
NCT02581046
Collaborator
Ministry of Health, China (Other)
61
1
2
35
1.7

Study Details

Study Description

Brief Summary

Congenital cataract is an important treatable cause of visual handicap in childhood throughout the world. Successful management of childhood cataract is dependent on individualized treatment strategies and rigorous postoperative supervision for adverse complication. In this trial, we aimed to compare the difference of postoperative outcome between surgical timing at age of 3 month and 6 month. Patients enrolled into the study will be followed for two year and will have study visits at 1 day, 1 week, 1 month, 3 month, 6 month, 9 month, 12 month, 18month and 24month postoperatively.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Phacomulsification lens removal cataract surgery without Intraocular lens(IOL) implantation at the age of 3month of the patients
  • Procedure: Phacomulsification lens removal cataract surgery without Intraocular lens(IOL) implantation at the age of 6 month of the patients
  • Drug: Subconjunctival dexamethasone and general anesthesia
N/A

Detailed Description

Congenital cataract is a priority of Vision 2020: the Right to Sight, the global initiative to reduce the world's burden of avoidable blindness, because it is an important treatable cause of visual handicap in childhood throughout the world. Successful management of childhood cataract is dependent on individualized treatment strategies and postoperative supervision for adverse complication is also essential. The timing of surgery of childhood cataract depends on the etiology and on the degree of visual interference. Severe bilateral cataracts with significant obstruction of the visual axis must be treated and surgery is recommended as soon as possible after discovery.

Several previous studies claimed that ideally cataracts should be removed before 3 months of age, while the result of recent researches shows that too early intervention for cataract surgery seems aggressive and would cause serious complications, which might cause poor long-term visual outcomes. Therefore, in order to control childhood blindness and severe visual impairment in China, it is of great importance to ensure that pediatric patients with cataract could have good timing of surgery, postoperative rigorous supervision, accurate optical rehabilitation and comprehensive treatment of amblyopia.

In this trial, we aimed to compare the difference of postoperative outcome between surgical timing at age of 3 month and 6 month. Patients enrolled into the study will be followed for two year and will have study visits at 1 day, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months, 18months and 24months after cataract surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
61 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of the Timing of Lens-removal Cataract Surgery on Postoperative Complications Rate Among Patients With Bilateral Congenital Cataracts
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Dec 1, 2013
Actual Study Completion Date :
Dec 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: 3 month surgical group

Phacoemulsification pediatric cataract surgery is performed at the age of 3 month of patients without IOL implantation.

Procedure: Phacomulsification lens removal cataract surgery without Intraocular lens(IOL) implantation at the age of 3month of the patients
The surgical timing of phacoemulsification is perform at the age of 3 month of the patients. During Phacoemulsification, viscoelastic materials and anterior lens capsule are used to protect corneal endothelial cells.

Drug: Subconjunctival dexamethasone and general anesthesia
All patients received subconjunctival dexamethasone (2 mg) during surgery, and all surgeries were performed under general anesthesia.

Experimental: 6 month surgical group

Phacoemulsification pediatric cataract surgery is performed at the age of 3 month of patients without IOL implantation..

Procedure: Phacomulsification lens removal cataract surgery without Intraocular lens(IOL) implantation at the age of 6 month of the patients
The surgical timing of phacoemulsification is perform at the age of 6 month of the patients. During Phacoemulsification, viscoelastic materials and anterior lens capsule are used to protect corneal endothelial cells.

Drug: Subconjunctival dexamethasone and general anesthesia
All patients received subconjunctival dexamethasone (2 mg) during surgery, and all surgeries were performed under general anesthesia.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in the central subfield thickness (CST) measured by Optical Coherence Tomography(OCT) [during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month]

  2. Change from baseline in the thickness of the inner retinal layer regions measured by Optical Coherence Tomography(OCT) [during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month]

  3. Change from baseline in the thickness of the outer retinal layer regions measured by Optical Coherence Tomography(OCT) [during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month]

Secondary Outcome Measures

  1. Number of participants with abnormal intraocular pressure or diagnosis with secondary glaucoma [2 year after surgery]

  2. Number of participants undergoing Nd:YAG laser capsulotomy due to severe posterior capsular opacification(PCO) [2 year after surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 3 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children diagnosis with bilateral congenital cataract for entire lens without other ocular abnormality

  • No more than 3 month old

  • Have signed a consent form

  • Can be followed

Exclusion Criteria:
  • Children not identified with congenital cataract

  • Have not signed consent form

  • Be not able to be followed

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhognshan Ophthalmic Center, Sun Yat-sen University Guangzhou Guangdong China 510060

Sponsors and Collaborators

  • Sun Yat-sen University
  • Ministry of Health, China

Investigators

  • Principal Investigator: Haotian Lin, M.D., Ph.D, Zhongshan Ophthalmic Center, Sun Yat-sen University
  • Study Chair: Yizhi Liu, M.D., Ph.D, Zhongshan Ophthalmic Center, Sun Yat-sen University
  • Study Director: Weirong Chen, M.D., Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Haotian Lin, Childhood Cataract Program of the Chinese Ministry of Health(CCPMOH), Zhongshan Ophthalmic Center, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT02581046
Other Study ID Numbers:
  • CCPMOH2010-China7
First Posted:
Oct 20, 2015
Last Update Posted:
Oct 20, 2015
Last Verified:
Oct 1, 2015
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 20, 2015